617 filings
8-K
VBIVQ
VBI Vaccines Inc
2 Aug 24
VBI Vaccines Provides an Update on its Restructuring Proceedings
4:05pm
8-K
VBIVQ
VBI Vaccines Inc
30 Jul 24
VBI Vaccines Initiates Restructuring Proceedings Under CCAA to Implement a Review of its Strategic Alternatives
10:28am
8-K
VBIVQ
VBI Vaccines Inc
25 Jun 24
VBI Vaccines Announces Results of Annual General Meeting
4:15pm
8-K
VBIVQ
VBI Vaccines Inc
29 May 24
VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients
8:00am
8-K
VBIVQ
VBI Vaccines Inc
24 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
nv35yox uisc
15 May 24
VBI Vaccines Reports First Quarter 2024 Financial Results
4:18pm
424B5
ljnev1ny b58rr5
15 May 24
Prospectus supplement for primary offering
4:16pm
8-K
dbwum 1zf
1 May 24
Other Events
4:15pm
ARS
n0yoje5pluzszm6kdsy5
29 Apr 24
Annual report to shareholders
4:15pm
DEFA14A
twu eg935d
29 Apr 24
Additional proxy soliciting materials
4:10pm
8-K
nypm1f
16 Apr 24
VBI Vaccines Reports Full Year 2023 Financial Results
8:00am
8-K
0wwvv3m5jb6g6w5
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
424B5
o37 52clg
11 Apr 24
Prospectus supplement for primary offering
9:06am
8-K
e0hwvzwkt4k3vf6
3 Apr 24
VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma
8:00am
8-K
nlq4jsl zlv3rxcn
2 Apr 24
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform
8:00am
NT 10-K
twj0i0mtfyy
28 Mar 24
Notice of late annual filing
4:15pm
8-K
df7dir192h6mbm2zt
14 Feb 24
VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences
8:34am